Status:

NOT_YET_RECRUITING

Postoperative Recovery Quality After Cesarean Section: Comparing Erector Spinae and Retrolaminar Blocks Using Turkish Version of the Obstetric Quality-of-Recovery Score in a Turkish Cohort (ObsQoR-11T)

Lead Sponsor:

Elazıg Fethi Sekin Sehir Hastanesi

Conditions:

Postoperative Pain Management

Eligibility:

FEMALE

18-45 years

Brief Summary

Study Design This retrospective observational study aims to evaluate and compare the effects of two regional anesthesia techniques, Erector Spinae Plane (ESP) block and Retrolaminar Block (RLB), on po...

Detailed Description

METHODS 1.1. Study Design and Settings This was a retrospective, single-center observational study conducted to evaluate the effects of ESP and RLB on postoperative pain, opioid consumption, and pati...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Women aged 18-45 years, scheduled for elective cesarean delivery under spinal anesthesia.
  • Gestational age ≥37 weeks, singleton pregnancy.
  • Undergoing either ESP or RLB for postoperative analgesia.
  • ASA Physical Status II-III.
  • Ability to understand and complete ObsQoR-11T questionnaire.
  • Provided written informed consent prior to participation. Exclusion Criteria
  • Emergency cesarean delivery.
  • Multiple pregnancy, preterm delivery (\<37 weeks),
  • Severe maternal or obstetric complications (e.g., preeclampsia, placenta previa, placenta accreta spectrum), regardless of urgency.
  • BMI ≥40 kg/m²
  • Significant systemic diseases (e.g., severe cardiac, respiratory, renal, or hepatic disease).
  • Fetal or placental anomalies.
  • History of chronic pain syndromes, opioid dependence, or long-term analgesic use.
  • Neurological, psychiatric, or cognitive disorders that may interfere with pain perception or questionnaire completion.
  • Patients who declined participation or did not provide informed consent.

Exclusion

    Key Trial Info

    Start Date :

    October 1 2025

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 15 2025

    Estimated Enrollment :

    60 Patients enrolled

    Trial Details

    Trial ID

    NCT07181902

    Start Date

    October 1 2025

    End Date

    December 15 2025

    Last Update

    September 30 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Elazığ Fethi Sekin City Hospital

    Elâzığ, Seçiniz, Turkey (Türkiye), 23100